Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | KW-2450 |
| Trade Name | |
| Synonyms | KW2450|KW 2450 |
| Drug Descriptions |
KW-2450 is a multitargeted kinase inhibitor with activity against Aurora A and B, and IGF-1R, which potentially results in decreased tumor cell growth (PMID: 26443806, PMID: 30083253). |
| DrugClasses | Aurka Inhibitors 27 Aurkb Inhibitors 21 IGF-1R Inhibitor 17 |
| CAS Registry Number | 1360433-93-7 |
| NCIT ID | C84871 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| KW-2450 | KW-2450 | 0 | 0 |
| KW-2450 + Selumetinib | KW-2450 Selumetinib | 0 | 0 |